A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

BACKGROUND: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of the seriou...

Descripción completa

Detalles Bibliográficos
Autores principales: Urakawa, Shinya, Sakai, Daisuke, Miyazaki, Yasuhiro, Kudo, Toshihiro, Katou, Aya, Inagaki, Chiaki, Tanaka, Koji, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Nakajima, Kiyokazu, Takiguchi, Shuji, Satoh, Taroh, Mori, Masaki, Doki, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736507/
https://www.ncbi.nlm.nih.gov/pubmed/29260338
http://dx.doi.org/10.1186/s40792-017-0399-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736507/
https://www.ncbi.nlm.nih.gov/pubmed/29260338
http://dx.doi.org/10.1186/s40792-017-0399-7

Ejemplares similares